GENE-42. THE GENOMIC LANDSCAPE OF TRIPLE-NEGATIVE GLIOBLASTOMA Article Swipe
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/neuonc/noy148.468
Glioblastoma (GBM) is the most common and deadly primary malignant brain tumor in adults. Mutations in the TERT promoter (TERTp) and isocitrate dehydrogenase 1 or 2 (IDH1/2) can classify ~80% of GBMs into molecular subgroups with distinct clinical courses. These molecular subgroups utilize distinct genetic mechanisms of telomere maintenance, either TERTp mutation leading to telomerase activation or ATRX-mutation leading to an alternative lengthening of telomeres phenotype (ALT). However, approximately 20% of GBMs lack alterations in TERTp and IDH1/2. These tumors, designated TERTp(WT)-IDH(WT) or triple-negative glioblastomas (as they also lack 1p19q co-deletion) do not have well-established genetic biomarkers or defined mechanisms of telomere maintenance. Here we performed whole-exome, whole-genome, and RNA-sequencing on a cohort of triple-negative GBMs to define their genetic landscape. We discovered recurrent inactivating mutations in SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1 (SMARCAL1) in 21% (8/39) of triple-negative GBMs. Using telomere maintenance characterization assays, we show that SMARCAL1-mutant cases exhibited the ALT phenotype. Using CRISPR/Cas9 gene editing in GBM cell lines, we found that inducing loss of SMARCAL1 generates features of ALT. Rescue of expression of SMARCAL1 in SMARCAL1-null cell lines markedly suppressed ALT features and was dependent on the enzyme helicase activity. Furthermore, using break-apart FISH and whole genome sequencing, we identified recurrent rearrangements upstream of TERT in ~50% of triple-negative GBMs. These TERT-rearranged tumors exhibited elevated levels of TERT mRNA expression. This represents a novel mechanism of telomerase activation in GBMs lacking the well-known TERT promoter hotspot mutations. Finally, we identify recurrent BRAF V600E mutations in younger patients with GBM. Collectively, our findings define novel molecular subgroups of glioblastoma, including a telomerase-positive subgroup driven by TERT-structural rearrangements (IDH(WT)-TERT(SV), ~50%), and an ALT-positive subgroup (IDH(WT)-ALT, ~40%) with mutations in ATRX or SMARCAL1. We also establish SMARCAL1 inactivating
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/neuonc/noy148.468
- https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdf
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2916011021
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2916011021Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/neuonc/noy148.468Digital Object Identifier
- Title
-
GENE-42. THE GENOMIC LANDSCAPE OF TRIPLE-NEGATIVE GLIOBLASTOMAWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-11-01Full publication date if available
- Authors
-
Bill H. Diplas, Matthew S. Waitkus, Xujun He, Jackie Brosnan-Cashman, Heng Liu, Lee Chen, Zhaohui Wang, Casey J. Moure, Patrick Killela, Eric Lipp, Fausto J. Rodríguez, Yuchen Jiao, Roger E. McLendon, Darell D. Bigner, Alan K. Meeker, Hai YanList of authors in order
- Landing page
-
https://doi.org/10.1093/neuonc/noy148.468Publisher landing page
- PDF URL
-
https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdfDirect OA link when available
- Concepts
-
Biology, Telomere, ATRX, Isocitrate dehydrogenase, Telomerase, Gene, Mutation, IDH1, Cancer research, Phenotype, Molecular biology, Genetics, Enzyme, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2916011021 |
|---|---|
| doi | https://doi.org/10.1093/neuonc/noy148.468 |
| ids.doi | https://doi.org/10.1093/neuonc/noy148.468 |
| ids.mag | 2916011021 |
| ids.openalex | https://openalex.org/W2916011021 |
| fwci | 0.0 |
| type | article |
| title | GENE-42. THE GENOMIC LANDSCAPE OF TRIPLE-NEGATIVE GLIOBLASTOMA |
| biblio.issue | suppl_6 |
| biblio.volume | 20 |
| biblio.last_page | vi112 |
| biblio.first_page | vi112 |
| topics[0].id | https://openalex.org/T12820 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9894999861717224 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Chromatin Remodeling and Cancer |
| topics[1].id | https://openalex.org/T10878 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9476000070571899 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | CRISPR and Genetic Engineering |
| topics[2].id | https://openalex.org/T10937 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9466000199317932 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2737 |
| topics[2].subfield.display_name | Physiology |
| topics[2].display_name | Telomeres, Telomerase, and Senescence |
| is_xpac | False |
| apc_list.value | 4612 |
| apc_list.currency | USD |
| apc_list.value_usd | 4612 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C86803240 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7367613911628723 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[0].display_name | Biology |
| concepts[1].id | https://openalex.org/C177336024 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7191590666770935 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q14872779 |
| concepts[1].display_name | Telomere |
| concepts[2].id | https://openalex.org/C2776689207 |
| concepts[2].level | 4 |
| concepts[2].score | 0.7172412872314453 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q17835753 |
| concepts[2].display_name | ATRX |
| concepts[3].id | https://openalex.org/C2777150147 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5593946576118469 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q261968 |
| concepts[3].display_name | Isocitrate dehydrogenase |
| concepts[4].id | https://openalex.org/C94581717 |
| concepts[4].level | 3 |
| concepts[4].score | 0.50087571144104 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q331839 |
| concepts[4].display_name | Telomerase |
| concepts[5].id | https://openalex.org/C104317684 |
| concepts[5].level | 2 |
| concepts[5].score | 0.48337048292160034 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[5].display_name | Gene |
| concepts[6].id | https://openalex.org/C501734568 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4726387858390808 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q42918 |
| concepts[6].display_name | Mutation |
| concepts[7].id | https://openalex.org/C127848430 |
| concepts[7].level | 4 |
| concepts[7].score | 0.4554460048675537 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q18027543 |
| concepts[7].display_name | IDH1 |
| concepts[8].id | https://openalex.org/C502942594 |
| concepts[8].level | 1 |
| concepts[8].score | 0.45419883728027344 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[8].display_name | Cancer research |
| concepts[9].id | https://openalex.org/C127716648 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4515003263950348 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q104053 |
| concepts[9].display_name | Phenotype |
| concepts[10].id | https://openalex.org/C153911025 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3970586061477661 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[10].display_name | Molecular biology |
| concepts[11].id | https://openalex.org/C54355233 |
| concepts[11].level | 1 |
| concepts[11].score | 0.38935989141464233 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[11].display_name | Genetics |
| concepts[12].id | https://openalex.org/C181199279 |
| concepts[12].level | 2 |
| concepts[12].score | 0.08879309892654419 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[12].display_name | Enzyme |
| concepts[13].id | https://openalex.org/C55493867 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[13].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/biology |
| keywords[0].score | 0.7367613911628723 |
| keywords[0].display_name | Biology |
| keywords[1].id | https://openalex.org/keywords/telomere |
| keywords[1].score | 0.7191590666770935 |
| keywords[1].display_name | Telomere |
| keywords[2].id | https://openalex.org/keywords/atrx |
| keywords[2].score | 0.7172412872314453 |
| keywords[2].display_name | ATRX |
| keywords[3].id | https://openalex.org/keywords/isocitrate-dehydrogenase |
| keywords[3].score | 0.5593946576118469 |
| keywords[3].display_name | Isocitrate dehydrogenase |
| keywords[4].id | https://openalex.org/keywords/telomerase |
| keywords[4].score | 0.50087571144104 |
| keywords[4].display_name | Telomerase |
| keywords[5].id | https://openalex.org/keywords/gene |
| keywords[5].score | 0.48337048292160034 |
| keywords[5].display_name | Gene |
| keywords[6].id | https://openalex.org/keywords/mutation |
| keywords[6].score | 0.4726387858390808 |
| keywords[6].display_name | Mutation |
| keywords[7].id | https://openalex.org/keywords/idh1 |
| keywords[7].score | 0.4554460048675537 |
| keywords[7].display_name | IDH1 |
| keywords[8].id | https://openalex.org/keywords/cancer-research |
| keywords[8].score | 0.45419883728027344 |
| keywords[8].display_name | Cancer research |
| keywords[9].id | https://openalex.org/keywords/phenotype |
| keywords[9].score | 0.4515003263950348 |
| keywords[9].display_name | Phenotype |
| keywords[10].id | https://openalex.org/keywords/molecular-biology |
| keywords[10].score | 0.3970586061477661 |
| keywords[10].display_name | Molecular biology |
| keywords[11].id | https://openalex.org/keywords/genetics |
| keywords[11].score | 0.38935989141464233 |
| keywords[11].display_name | Genetics |
| keywords[12].id | https://openalex.org/keywords/enzyme |
| keywords[12].score | 0.08879309892654419 |
| keywords[12].display_name | Enzyme |
| language | en |
| locations[0].id | doi:10.1093/neuonc/noy148.468 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S106908163 |
| locations[0].source.issn | 1522-8517, 1523-5866 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1522-8517 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Neuro-Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Neuro-Oncology |
| locations[0].landing_page_url | https://doi.org/10.1093/neuonc/noy148.468 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:6216930 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Neuro Oncol |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6216930 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5003944261 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9248-7351 |
| authorships[0].author.display_name | Bill H. Diplas |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[0].affiliations[0].raw_affiliation_string | Duke University Medical Center, Durham, NC, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[0].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Duke Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Bill Diplas |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Duke University Medical Center, Durham, NC, USA |
| authorships[1].author.id | https://openalex.org/A5088890711 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-7116-6978 |
| authorships[1].author.display_name | Matthew S. Waitkus |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[1].affiliations[0].raw_affiliation_string | Duke University Medical Center, Durham, NC, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[1].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Duke Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Matthew Waitkus |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Duke University Medical Center, Durham, NC, USA |
| authorships[2].author.id | https://openalex.org/A5100715896 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-6979-2072 |
| authorships[2].author.display_name | Xujun He |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[2].affiliations[0].raw_affiliation_string | Duke University School of Medicine, Durham, NC, USA |
| authorships[2].institutions[0].id | https://openalex.org/I170897317 |
| authorships[2].institutions[0].ror | https://ror.org/00py81415 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Duke University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Xujun He |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Duke University School of Medicine, Durham, NC, USA |
| authorships[3].author.id | https://openalex.org/A5013216549 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Jackie Brosnan-Cashman |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[3].affiliations[0].raw_affiliation_string | Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[3].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[3].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[3].institutions[1].id | https://openalex.org/I145311948 |
| authorships[3].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | Johns Hopkins University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jackie Brosnan-Cashman |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[4].author.id | https://openalex.org/A5038400742 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5702-2361 |
| authorships[4].author.display_name | Heng Liu |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[4].affiliations[0].raw_affiliation_string | Duke University School of Medicine, Durham, NC, USA |
| authorships[4].institutions[0].id | https://openalex.org/I170897317 |
| authorships[4].institutions[0].ror | https://ror.org/00py81415 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Duke University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Heng Liu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Duke University School of Medicine, Durham, NC, USA |
| authorships[5].author.id | https://openalex.org/A5010042613 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Lee Chen |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[5].affiliations[0].raw_affiliation_string | Duke University School of Medicine, Durham, NC, USA |
| authorships[5].institutions[0].id | https://openalex.org/I170897317 |
| authorships[5].institutions[0].ror | https://ror.org/00py81415 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Duke University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lee Chen |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Duke University School of Medicine, Durham, NC, USA |
| authorships[6].author.id | https://openalex.org/A5100358047 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-5872-5712 |
| authorships[6].author.display_name | Zhaohui Wang |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[6].affiliations[0].raw_affiliation_string | Duke University School of Medicine, Durham, NC, USA |
| authorships[6].institutions[0].id | https://openalex.org/I170897317 |
| authorships[6].institutions[0].ror | https://ror.org/00py81415 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Duke University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Zhaohui Wang |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Duke University School of Medicine, Durham, NC, USA |
| authorships[7].author.id | https://openalex.org/A5019381652 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-5094-2213 |
| authorships[7].author.display_name | Casey J. Moure |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[7].affiliations[0].raw_affiliation_string | Duke University School of Medicine, Durham, NC, USA |
| authorships[7].institutions[0].id | https://openalex.org/I170897317 |
| authorships[7].institutions[0].ror | https://ror.org/00py81415 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Duke University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Casey Moure |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Duke University School of Medicine, Durham, NC, USA |
| authorships[8].author.id | https://openalex.org/A5073957378 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Patrick Killela |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[8].affiliations[0].raw_affiliation_string | Duke University School of Medicine, Durham, NC, USA |
| authorships[8].institutions[0].id | https://openalex.org/I170897317 |
| authorships[8].institutions[0].ror | https://ror.org/00py81415 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Duke University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Patrick Killela |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Duke University School of Medicine, Durham, NC, USA |
| authorships[9].author.id | https://openalex.org/A5045697502 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4372-5533 |
| authorships[9].author.display_name | Eric Lipp |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210126298, https://openalex.org/I4210153043 |
| authorships[9].affiliations[0].raw_affiliation_string | The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA |
| authorships[9].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[9].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Duke Medical Center |
| authorships[9].institutions[1].id | https://openalex.org/I4210153043 |
| authorships[9].institutions[1].ror | https://ror.org/04bct7p84 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876, https://openalex.org/I4210144876, https://openalex.org/I4210153043 |
| authorships[9].institutions[1].country_code | US |
| authorships[9].institutions[1].display_name | Duke University Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Eric Lipp |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA |
| authorships[10].author.id | https://openalex.org/A5100605108 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8662-1219 |
| authorships[10].author.display_name | Fausto J. Rodríguez |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[10].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[10].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[10].institutions[1].id | https://openalex.org/I145311948 |
| authorships[10].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | Johns Hopkins University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Fausto Rodriguez |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[11].author.id | https://openalex.org/A5091120394 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-7917-8810 |
| authorships[11].author.display_name | Yuchen Jiao |
| authorships[11].countries | CN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I200296433 |
| authorships[11].affiliations[0].raw_affiliation_string | State Key Laboratory of Molecular Oncology, Laboratory of Cell and Molecular Biology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China |
| authorships[11].institutions[0].id | https://openalex.org/I200296433 |
| authorships[11].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Yuchen Jiao |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | State Key Laboratory of Molecular Oncology, Laboratory of Cell and Molecular Biology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China |
| authorships[12].author.id | https://openalex.org/A5073862375 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-6682-4588 |
| authorships[12].author.display_name | Roger E. McLendon |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I170897317 |
| authorships[12].affiliations[0].raw_affiliation_string | Duke University, Durham, NC, USA |
| authorships[12].institutions[0].id | https://openalex.org/I170897317 |
| authorships[12].institutions[0].ror | https://ror.org/00py81415 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I170897317 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Duke University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Roger McLendon |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Duke University, Durham, NC, USA |
| authorships[13].author.id | https://openalex.org/A5004814459 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-5548-4899 |
| authorships[13].author.display_name | Darell D. Bigner |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[13].affiliations[0].raw_affiliation_string | Duke University Medical Center, Durham, NC, USA |
| authorships[13].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[13].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Duke Medical Center |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Darell Bigner |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Duke University Medical Center, Durham, NC, USA |
| authorships[14].author.id | https://openalex.org/A5028865365 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-4601-6481 |
| authorships[14].author.display_name | Alan K. Meeker |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I145311948, https://openalex.org/I2799853436 |
| authorships[14].affiliations[0].raw_affiliation_string | Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[14].institutions[0].id | https://openalex.org/I2799853436 |
| authorships[14].institutions[0].ror | https://ror.org/037zgn354 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I2799853436 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Johns Hopkins Medicine |
| authorships[14].institutions[1].id | https://openalex.org/I145311948 |
| authorships[14].institutions[1].ror | https://ror.org/00za53h95 |
| authorships[14].institutions[1].type | education |
| authorships[14].institutions[1].lineage | https://openalex.org/I145311948 |
| authorships[14].institutions[1].country_code | US |
| authorships[14].institutions[1].display_name | Johns Hopkins University |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Alan Meeker |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| authorships[15].author.id | https://openalex.org/A5034933958 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-9509-8431 |
| authorships[15].author.display_name | Hai Yan |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[15].affiliations[0].raw_affiliation_string | Duke University Medical Center, Durham, NC, USA |
| authorships[15].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[15].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Duke Medical Center |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Hai Yan |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Duke University Medical Center, Durham, NC, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | GENE-42. THE GENOMIC LANDSCAPE OF TRIPLE-NEGATIVE GLIOBLASTOMA |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12820 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9894999861717224 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Chromatin Remodeling and Cancer |
| related_works | https://openalex.org/W2417511905, https://openalex.org/W2103156000, https://openalex.org/W60632522, https://openalex.org/W2127443475, https://openalex.org/W2090447055, https://openalex.org/W2005903392, https://openalex.org/W2400859286, https://openalex.org/W2128765444, https://openalex.org/W4366704913, https://openalex.org/W2760885207 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/neuonc/noy148.468 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S106908163 |
| best_oa_location.source.issn | 1522-8517, 1523-5866 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1522-8517 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Neuro-Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Neuro-Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1093/neuonc/noy148.468 |
| primary_location.id | doi:10.1093/neuonc/noy148.468 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S106908163 |
| primary_location.source.issn | 1522-8517, 1523-5866 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1522-8517 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Neuro-Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi112/26280959/noy148.468.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Neuro-Oncology |
| primary_location.landing_page_url | https://doi.org/10.1093/neuonc/noy148.468 |
| publication_date | 2018-11-01 |
| publication_year | 2018 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 23, 135 |
| abstract_inverted_index.2 | 25 |
| abstract_inverted_index.a | 111, 229, 266 |
| abstract_inverted_index.We | 121, 287 |
| abstract_inverted_index.an | 60, 276 |
| abstract_inverted_index.by | 270 |
| abstract_inverted_index.do | 91 |
| abstract_inverted_index.in | 12, 15, 74, 126, 137, 161, 181, 212, 235, 251, 283 |
| abstract_inverted_index.is | 2 |
| abstract_inverted_index.of | 30, 46, 63, 70, 100, 113, 131, 140, 170, 174, 177, 179, 210, 214, 223, 232, 263 |
| abstract_inverted_index.on | 110, 192 |
| abstract_inverted_index.or | 24, 56, 82, 97, 285 |
| abstract_inverted_index.to | 53, 59, 116 |
| abstract_inverted_index.we | 104, 148, 165, 205, 245 |
| abstract_inverted_index.(as | 85 |
| abstract_inverted_index.20% | 69 |
| abstract_inverted_index.21% | 138 |
| abstract_inverted_index.ALT | 155, 187 |
| abstract_inverted_index.GBM | 162 |
| abstract_inverted_index.and | 6, 20, 76, 108, 189, 201, 275 |
| abstract_inverted_index.can | 27 |
| abstract_inverted_index.not | 92 |
| abstract_inverted_index.our | 257 |
| abstract_inverted_index.the | 3, 16, 154, 193, 238 |
| abstract_inverted_index.was | 190 |
| abstract_inverted_index.ALT. | 175 |
| abstract_inverted_index.ATRX | 284 |
| abstract_inverted_index.BRAF | 248 |
| abstract_inverted_index.FISH | 200 |
| abstract_inverted_index.GBM. | 255 |
| abstract_inverted_index.GBMs | 31, 71, 115, 236 |
| abstract_inverted_index.Here | 103 |
| abstract_inverted_index.TERT | 17, 211, 224, 240 |
| abstract_inverted_index.This | 227 |
| abstract_inverted_index.also | 87, 288 |
| abstract_inverted_index.cell | 163, 183 |
| abstract_inverted_index.gene | 159 |
| abstract_inverted_index.have | 93 |
| abstract_inverted_index.into | 32 |
| abstract_inverted_index.lack | 72, 88 |
| abstract_inverted_index.loss | 169 |
| abstract_inverted_index.mRNA | 225 |
| abstract_inverted_index.most | 4 |
| abstract_inverted_index.show | 149 |
| abstract_inverted_index.that | 150, 167 |
| abstract_inverted_index.they | 86 |
| abstract_inverted_index.with | 35, 254, 281 |
| abstract_inverted_index.~50% | 213 |
| abstract_inverted_index.~80% | 29 |
| abstract_inverted_index.(GBM) | 1 |
| abstract_inverted_index.1p19q | 89 |
| abstract_inverted_index.GBMs. | 142, 216 |
| abstract_inverted_index.TERTp | 50, 75 |
| abstract_inverted_index.These | 39, 78, 217 |
| abstract_inverted_index.Using | 143, 157 |
| abstract_inverted_index.V600E | 249 |
| abstract_inverted_index.brain | 10 |
| abstract_inverted_index.cases | 152 |
| abstract_inverted_index.found | 166 |
| abstract_inverted_index.lines | 184 |
| abstract_inverted_index.novel | 230, 260 |
| abstract_inverted_index.their | 118 |
| abstract_inverted_index.tumor | 11 |
| abstract_inverted_index.using | 198 |
| abstract_inverted_index.whole | 202 |
| abstract_inverted_index.~40%) | 280 |
| abstract_inverted_index.(8/39) | 139 |
| abstract_inverted_index.(ALT). | 66 |
| abstract_inverted_index.A-like | 134 |
| abstract_inverted_index.Rescue | 176 |
| abstract_inverted_index.cohort | 112 |
| abstract_inverted_index.common | 5 |
| abstract_inverted_index.deadly | 7 |
| abstract_inverted_index.define | 117, 259 |
| abstract_inverted_index.driven | 269 |
| abstract_inverted_index.either | 49 |
| abstract_inverted_index.enzyme | 194 |
| abstract_inverted_index.genome | 203 |
| abstract_inverted_index.levels | 222 |
| abstract_inverted_index.lines, | 164 |
| abstract_inverted_index.tumors | 219 |
| abstract_inverted_index.~50%), | 274 |
| abstract_inverted_index.(TERTp) | 19 |
| abstract_inverted_index.IDH1/2. | 77 |
| abstract_inverted_index.adults. | 13 |
| abstract_inverted_index.assays, | 147 |
| abstract_inverted_index.defined | 98 |
| abstract_inverted_index.editing | 160 |
| abstract_inverted_index.genetic | 44, 95, 119 |
| abstract_inverted_index.hotspot | 242 |
| abstract_inverted_index.lacking | 237 |
| abstract_inverted_index.leading | 52, 58 |
| abstract_inverted_index.primary | 8 |
| abstract_inverted_index.tumors, | 79 |
| abstract_inverted_index.utilize | 42 |
| abstract_inverted_index.younger | 252 |
| abstract_inverted_index.(IDH1/2) | 26 |
| abstract_inverted_index.Finally, | 244 |
| abstract_inverted_index.However, | 67 |
| abstract_inverted_index.SMARCAL1 | 171, 180, 290 |
| abstract_inverted_index.classify | 28 |
| abstract_inverted_index.clinical | 37 |
| abstract_inverted_index.courses. | 38 |
| abstract_inverted_index.distinct | 36, 43 |
| abstract_inverted_index.elevated | 221 |
| abstract_inverted_index.features | 173, 188 |
| abstract_inverted_index.findings | 258 |
| abstract_inverted_index.helicase | 195 |
| abstract_inverted_index.identify | 246 |
| abstract_inverted_index.inducing | 168 |
| abstract_inverted_index.markedly | 185 |
| abstract_inverted_index.mutation | 51 |
| abstract_inverted_index.patients | 253 |
| abstract_inverted_index.promoter | 18, 241 |
| abstract_inverted_index.subgroup | 268, 278 |
| abstract_inverted_index.telomere | 47, 101, 144 |
| abstract_inverted_index.upstream | 209 |
| abstract_inverted_index.Mutations | 14 |
| abstract_inverted_index.SMARCAL1. | 286 |
| abstract_inverted_index.activity. | 196 |
| abstract_inverted_index.dependent | 191 |
| abstract_inverted_index.establish | 289 |
| abstract_inverted_index.exhibited | 153, 220 |
| abstract_inverted_index.generates | 172 |
| abstract_inverted_index.including | 265 |
| abstract_inverted_index.malignant | 9 |
| abstract_inverted_index.mechanism | 231 |
| abstract_inverted_index.molecular | 33, 40, 261 |
| abstract_inverted_index.mutations | 125, 250, 282 |
| abstract_inverted_index.performed | 105 |
| abstract_inverted_index.phenotype | 65 |
| abstract_inverted_index.recurrent | 123, 207, 247 |
| abstract_inverted_index.regulator | 130 |
| abstract_inverted_index.subfamily | 133 |
| abstract_inverted_index.subgroups | 34, 41, 262 |
| abstract_inverted_index.telomeres | 64 |
| abstract_inverted_index.(SMARCAL1) | 136 |
| abstract_inverted_index.activation | 55, 234 |
| abstract_inverted_index.biomarkers | 96 |
| abstract_inverted_index.chromatin, | 132 |
| abstract_inverted_index.designated | 80 |
| abstract_inverted_index.discovered | 122 |
| abstract_inverted_index.expression | 178 |
| abstract_inverted_index.identified | 206 |
| abstract_inverted_index.isocitrate | 21 |
| abstract_inverted_index.landscape. | 120 |
| abstract_inverted_index.mechanisms | 45, 99 |
| abstract_inverted_index.mutations. | 243 |
| abstract_inverted_index.phenotype. | 156 |
| abstract_inverted_index.represents | 228 |
| abstract_inverted_index.suppressed | 186 |
| abstract_inverted_index.telomerase | 54, 233 |
| abstract_inverted_index.well-known | 239 |
| abstract_inverted_index.CRISPR/Cas9 | 158 |
| abstract_inverted_index.alterations | 73 |
| abstract_inverted_index.alternative | 61 |
| abstract_inverted_index.break-apart | 199 |
| abstract_inverted_index.expression. | 226 |
| abstract_inverted_index.lengthening | 62 |
| abstract_inverted_index.maintenance | 145 |
| abstract_inverted_index.sequencing, | 204 |
| abstract_inverted_index.ALT-positive | 277 |
| abstract_inverted_index.Furthermore, | 197 |
| abstract_inverted_index.Glioblastoma | 0 |
| abstract_inverted_index.co-deletion) | 90 |
| abstract_inverted_index.inactivating | 124, 291 |
| abstract_inverted_index.maintenance, | 48 |
| abstract_inverted_index.maintenance. | 102 |
| abstract_inverted_index.whole-exome, | 106 |
| abstract_inverted_index.(IDH(WT)-ALT, | 279 |
| abstract_inverted_index.ATRX-mutation | 57 |
| abstract_inverted_index.Collectively, | 256 |
| abstract_inverted_index.SMARCAL1-null | 182 |
| abstract_inverted_index.approximately | 68 |
| abstract_inverted_index.dehydrogenase | 22 |
| abstract_inverted_index.glioblastoma, | 264 |
| abstract_inverted_index.glioblastomas | 84 |
| abstract_inverted_index.whole-genome, | 107 |
| abstract_inverted_index.RNA-sequencing | 109 |
| abstract_inverted_index.rearrangements | 208, 272 |
| abstract_inverted_index.SMARCAL1-mutant | 151 |
| abstract_inverted_index.TERT-rearranged | 218 |
| abstract_inverted_index.TERT-structural | 271 |
| abstract_inverted_index.actin-dependent | 129 |
| abstract_inverted_index.triple-negative | 83, 114, 141, 215 |
| abstract_inverted_index.SWI/SNF-related, | 127 |
| abstract_inverted_index.characterization | 146 |
| abstract_inverted_index.well-established | 94 |
| abstract_inverted_index.TERTp(WT)-IDH(WT) | 81 |
| abstract_inverted_index.(IDH(WT)-TERT(SV), | 273 |
| abstract_inverted_index.matrix-associated, | 128 |
| abstract_inverted_index.telomerase-positive | 267 |
| cited_by_percentile_year | |
| countries_distinct_count | 2 |
| institutions_distinct_count | 16 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/15 |
| sustainable_development_goals[0].score | 0.5799999833106995 |
| sustainable_development_goals[0].display_name | Life in Land |
| citation_normalized_percentile.value | 0.14191929 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |